Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Boundless Bio, Inc. - Common Stock
(NQ:
BOLD
)
2.975
+0.075 (+2.59%)
Streaming Delayed Price
Updated: 10:36 AM EDT, Aug 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
21,721
Open
2.910
Bid (Size)
2.960 (1,100)
Ask (Size)
2.990 (500)
Prev. Close
2.900
Today's Range
2.910 - 2.990
52wk Range
0.9612 - 3.010
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Halper Sadeh LLC is Investigating Whether DAN, ESI, NUVL, BOLD are Obtaining Fair Deals for their Shareholders
July 06, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Element Solutions Inc. (NYSE – ESI), Boundless Bio Inc. (Nasdaq – BOLD), Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN)
July 06, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
Performance
YTD
+143.9%
+143.9%
1 Month
+20.0%
+20.0%
3 Month
+105.2%
+105.2%
6 Month
+152.1%
+152.1%
1 Year
+161.0%
+161.0%
More News
Read More
Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders
July 02, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
These stocks are moving in today's session
↗
June 23, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Tuesday?
↗
June 23, 2026
Via
Chartmill
BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders
June 23, 2026
From
Halper Sadeh LLC
Via
Business Wire
The market is filled with gapping stocks in Tuesday's session.
↗
June 23, 2026
Via
Chartmill
What's going on in today's pre-market session
↗
June 23, 2026
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
June 23, 2026
Via
Benzinga
Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement
June 23, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Targets Next Wave of DNA Damage Response Cancer Therapies
June 22, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
June 22, 2026
Via
Investor Brand Network
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
May 08, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
April 17, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Tuesday's session: gap up and gap down stocks
↗
April 14, 2026
Via
Chartmill
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
March 17, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
March 09, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Leerink Global Healthcare Conference
March 04, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 05, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
January 20, 2026
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
November 05, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio (BOLD) Q2 R&D Drops 17%
↗
August 05, 2025
Via
The Motley Fool
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
August 05, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Boundless Bio, Inc. - Common Stock publicly traded?
Yes, Boundless Bio, Inc. - Common Stock is publicly traded.
What exchange does Boundless Bio, Inc. - Common Stock trade on?
Boundless Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Boundless Bio, Inc. - Common Stock?
The ticker symbol for Boundless Bio, Inc. - Common Stock is BOLD on the Nasdaq Stock Market
What is the current price of Boundless Bio, Inc. - Common Stock?
The current price of Boundless Bio, Inc. - Common Stock is 2.975
When was Boundless Bio, Inc. - Common Stock last traded?
The last trade of Boundless Bio, Inc. - Common Stock was at 08/21/26 10:36 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
